Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
19.34
-1.99 (-9.33%)
At close: Oct 17, 2025, 4:00 PM EDT
19.02
-0.32 (-1.65%)
After-hours: Oct 17, 2025, 7:55 PM EDT
Progyny Market Cap
Progyny has a market cap or net worth of $1.66 billion as of October 17, 2025. Its market cap has increased by 12.80% in one year.
Market Cap
1.66B
Enterprise Value
1.39B
1-Year Change
12.80%
Ranking
Category
Stock Price
$19.34
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $1.66B, an increase of 26.95%. That is a compound annual growth rate of 4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.66B | 13.21% |
| Dec 31, 2024 | 1.47B | -58.78% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.60B |
| Johnson & Johnson | 464.59B |
| AbbVie | 405.12B |
| UnitedHealth Group | 321.28B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 223.06B |